Basit öğe kaydını göster

dc.contributor.authorGuveli, Murat Emin
dc.contributor.authorSoydinc, Hilal Oguz
dc.contributor.authorSerilmez, Murat
dc.contributor.authorKaradeniz, Ahmet
dc.contributor.authorBilgin, Elif
dc.contributor.authorDuranyildiz, Derya
dc.contributor.authorYasasever, Vildan
dc.date.accessioned2021-03-03T10:03:47Z
dc.date.available2021-03-03T10:03:47Z
dc.date.issued2016
dc.identifier.citationGuveli M. E. , Duranyildiz D., Karadeniz A., Bilgin E., Serilmez M., Soydinc H. O. , Yasasever V., "Circulating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients", TUMOR BIOLOGY, cilt.37, sa.7, ss.8979-8983, 2016
dc.identifier.issn1010-4283
dc.identifier.otherav_207565b9-6711-4e2b-aade-6d4f0cf15154
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/26890
dc.identifier.urihttps://doi.org/10.1007/s13277-015-4777-0
dc.description.abstractWe aimed to determine the serum levels of angiogenic factors, namely angiopoietins, in nasopharyngeal and laryngeal carcinoma patients. We also aimed to seek the relation of these molecules with tumor grade and their utility as diagnostic biomarkers. We evaluated angiopoietin 1 and 2 levels innasopharynx and larynx cancer patients before treatment. Angiopoietin 2 levels were significantly elevated in larynx carcinoma patients and tended to be elevated in nasopharynx cancer patients compared with healthy controls. However, angiopoietin 1 levels were similar in cancer patients and controls. Angiopoietin 1 levels were significantly higher in nasopharyngeal cancer patients with advanced stages compared to earlier stages. On the other hand, angiopoietin 2 levels were similar in advanced and earlier stage cancer patients.
dc.language.isoeng
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleCirculating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients
dc.typeMakale
dc.relation.journalTUMOR BIOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume37
dc.identifier.issue7
dc.identifier.startpage8979
dc.identifier.endpage8983
dc.contributor.firstauthorID101703


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster